Amazon Biotech (OTCBB: AMZB) is Profiled in this Database

Updated At 15 Dec, 2011

Partial description of this company

Developing a whole-plant therapeutic, AMZ0026, that exhibits immunomodulator properties for the treatment of HIV/AIDS. Preliminary clinical studies in patients that are seropositive for HIV-1 have demonstrated a positive effect on CD4 and CD4/CD8 blood serum levels.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Amazon Biotech (OTCBB: AMZB) plus 4816 other startups.

Start Free 7 Day Trial Now

Learn More About Amazon Biotech (OTCBB: AMZB)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation